Clinical Trial Update: Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of omega-3 fatty acid supplements in heavy smokers with lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Omega-3 Fatty Acid Supplements (Omega-3 fatty acids)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN